Distribution of PCR ribotypes in regions of Hungary Free

Abstract

The objective of this survey was to determine the distribution of PCR ribotypes present across three Hungarian geographical regions. A total of 105 isolates of from diarrhoeal faeces of both inpatients and outpatients were examined. The toxigenic status of the strains was determined by PCR for the , , and genes in Szeged (Hungary), while strains were subjected to PCR ribotyping in Cardiff (UK). A total of 31 ribotypes were detected among the 105 isolates tested. Five PCR ribotypes were distinct from all previously described types, suggesting that they are new. The most common types in Hungary, during the period examined, were PCR ribotype 014 (24·8 %) and PCR ribotype 002 (13·3 %). The distribution of PCR ribotypes differed in the various Hungarian regions: PCR ribotype 012 was frequent (20·7 %) in South Hungary, whereas this type was rare in the Budapest region and was not common to West Hungary. In West Hungary and the Budapest region, PCR ribotype 014 was most frequent (28·9 and 29 %, respectively).

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46141-0
2006-03-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/3/279.html?itemId=/content/journal/jmm/10.1099/jmm.0.46141-0&mimeType=html&fmt=ahah

References

  1. Barbut F., Leluan P., Antoniotti G., Collignon A., Sedallian A., Petit J. C. 1995; Value of routine stool cultures in hospitalized patients with diarrhea. Eur J Clin Microbiol Infect Dis 14:346–349 [CrossRef]
    [Google Scholar]
  2. Barbut F., Decre D., Lalande V. & 9 other authors; 2005; Clinical features of Clostridium difficile -associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 54:Suppl.181–185 [CrossRef]
    [Google Scholar]
  3. Bartlett J. G. 1992; Antibiotic-associated diarrhea. Clin Infect Dis 15:573–581 [CrossRef]
    [Google Scholar]
  4. Brazier J. S. 2001; Typing of Clostridium difficile . Clin Microbiol Infect 7:428–431 [CrossRef]
    [Google Scholar]
  5. Brown E., Talbot G. H., Axelrod P., Provencher M., Hoegg C. 1990; Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 11:283–290 [CrossRef]
    [Google Scholar]
  6. Hyett A. P., Brazier J. S., O'Neil G. L. 1997; Pulsed-field gel electrophoresis as a method for typing Clostridium difficile in the routine laboratory. Rev Med Microbiol 8:Suppl.63–64 [CrossRef]
    [Google Scholar]
  7. Kato N., Ou C. Y., Kato H., Bartley S., Brown V. K., Dowell V. R., Ueno K. 1991; Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol 29:33–37
    [Google Scholar]
  8. Kato H., Kato N., Watanabe K., Ueno K., Sakata Y., Fujita K. 1996; Relapses or reinfections: analysis of a case of Clostridium difficile -associated colitis by two typing systems. Curr Opin Microbiol 33:220–223 [CrossRef]
    [Google Scholar]
  9. Kato H., Kato N., Watanabe K. & 7 other authors; 1998; Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 36:2178–2182
    [Google Scholar]
  10. McFarland L. V. 1995; Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients. Am J Infect Control 23:295–305 [CrossRef]
    [Google Scholar]
  11. Noren T., Akerlund T., Back E., Sjoberg L., Persson I., Alriksson I., Burman L. G. 2004; Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol 42:3635–3643 [CrossRef]
    [Google Scholar]
  12. Riley T. V., Cooper M., Bell B., Golledge C. L. 1995; Community-acquired Clostridium difficile -associated diarrhea. Clin Infect Dis 20:Suppl.263–265 [CrossRef]
    [Google Scholar]
  13. Rotimi V. O., Jama W. Y., Mokaddas E. M., Brazier J. S., Johny M., Duerden B. I. 2003; Prevalent PCR ribotypes of clinical and environmental strains of Clostridium difficile isolated from intensive-therapy unit patients in Kuwait. J Med Microbiol 52:705–709 [CrossRef]
    [Google Scholar]
  14. Spencer R. C. 1998; Clinical impact and associated costs of Clostridium difficile -associated disease. J Antimicrob Chemother 41:Suppl.5–12 [CrossRef]
    [Google Scholar]
  15. Stubbs S. L. J., Brazier J. S., O'Neil G. L., Duerden B. I. 1999; PCR targeted to the 16S–23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37:461–463
    [Google Scholar]
  16. Stubbs S., Rupnik M., Gibert M., Brazier J., Duerden B., Popoff M. 2000; Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of C. difficile . FEMS Microbiol Lett 186:307–312 [CrossRef]
    [Google Scholar]
  17. Terhes G., Urbán E., Sóki J., Hamid K. A., Nagy E. 2004; Community-acquired Clostridium difficile caused by binary toxin, toxin A, toxin B gene-positive isolates in Hungary. J Clin Microbiol 42:4316–4318 [CrossRef]
    [Google Scholar]
  18. Urbán E., Brazier J. S., Sóki J., Nagy E., Duerden B. I. 2001; PCR ribotyping of clinically important Clostridium difficile strains from Hungary. J Med Microbiol 50:1082–1086
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46141-0
Loading
/content/journal/jmm/10.1099/jmm.0.46141-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed